ISPE Drug Shortages Initiative Core Team

Placeholder Person Graphic
ISPE’s Drug Shortages Initiative focuses on the technical, scientific, manufacturing, quality and compliance issues associated with a company’s supply chain and related to its ability to source, manufacture and distribute products that have resulted in drug shortages.

Related Articles

Drug Shortages: Looking Forward with Regulator Insight
iSpeak Blog
Drug Shortages: Looking Forward with Regulator Insight

During 2020, the pressure points of the COVID-19 pandemic challenged us to broaden our thinking and change our practices. Adjustments were made at a global scale and more people were immersed in the experience of dealing with a crisis than ever before. This generated a spotlight on pharmaceutical supply chain practices. Patients and regulators were increasingly asking: what are best practices...